Crossref
Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy
Circulation · 23.06.2026 · 153 (25) · 1949-1951
DOI: 10.1161/circulationaha.125.078939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 23.06.2026. Verfasst von Degang Mo und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Qingdao University, Qingdao, 266000, China (D.M.). Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
cardiovascular diseaseslipoprotein(a)primary prevention
Autor:innen und Institutionen
- School of Medicine, Qingdao University, Qingdao, 266000, China (D.M.).
- Department of Cardiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Shinan District, China (H.D.).
ORCID-Profile: Degang Mo, Hongyan Dai
Zitieren
APA
Mo, D., & Dai, H. (2026). Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy. Circulation, 153(25), 1949-1951. https://doi.org/10.1161/circulationaha.125.078939
Vancouver
Mo D, Dai H. Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy. Circulation. 2026;153(25):1949-1951. doi:10.1161/circulationaha.125.078939
BibTeX
@article{Mo2026,
author = {Mo, Degang and Dai, Hongyan},
title = {Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy},
journal = {Circulation},
year = {2026},
volume = {153},
number = {25},
pages = {1949--1951},
doi = {10.1161/circulationaha.125.078939}
}
EUVIMED